文献速递皮肤肿瘤

伴有淋巴血管侵犯的皮肤鳞状细胞癌转移率和死亡率更高

Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
PubMed 文献 · J Am Acad Dermatol · 2021-11-11

这项为期20年的回顾性多中心队列研究分析了10,707例皮肤鳞状细胞癌肿瘤,按有无淋巴血管侵犯(LVI)分层。低分期(BWH T1/T2a)肿瘤中,LVI+组5年局部复发、转移和疾病特异性死亡累积发生率均显著高于LVI-组;高分期(BWH T2b/T3)肿瘤中,LVI+组转移和疾病特异性死亡发生率更高,但局部复发无差异。结论认为LVI+皮肤鳞状细胞癌5年转移和死亡风险更高,未来分期系统应考虑纳入LVI。

要点

  • 低分期(BWH T1/T2a)皮肤鳞状细胞癌中,LVI+组5年转移累积发生率为4.2%,LVI-组为0.4%(P<.01)。
  • 低分期肿瘤中,LVI+组5年疾病特异性死亡累积发生率为16.2%,LVI-组为0.4%(P<.01)。
  • 高分期(BWH T2b/T3)肿瘤中,LVI+组5年疾病特异性死亡累积发生率为25.3%,LVI-组为13.9%(P=.03)。

核心结论

  • LVI+皮肤鳞状细胞癌在5年时具有更高的转移率和死亡率。
  • 未来分期系统应考虑纳入LVI。

研究设计与样本

  • 回顾性、多中心队列研究,纳入20年间10,707例皮肤鳞状细胞癌肿瘤,按LVI存在(LVI+)或缺失(LVI-)分层。

主要发现

  • 10,707例肿瘤中78例有LVI。
  • 低分期(BWH T1/T2a)肿瘤中,LVI+组 vs LVI-组5年局部复发累积发生率为12.3% vs 1.1%(P<.01),转移为4.2% vs 0.4%(P<.01),疾病特异性死亡为16.2% vs 0.4%(P<.01)。
  • 高分期(BWH T2b/T3)肿瘤中,LVI+组 vs LVI-组5年转移累积发生率为28.5% vs 16.8%(P=.06),疾病特异性死亡为25.3% vs 13.9%(P=.03),局部复发为16.3% vs 15.8%(P=.11)。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphovascular invasion (LVI) is an aggressive histologic finding but is excluded from current staging systems due to its lack of demonstrated independent prognostic significance. OBJECTIVE: To evaluate the impact of LVI on cutaneous squamous cell carcinoma tumor outcomes. METHODS: In total, 10,707 cutaneous squamous cell carcinoma tumors from a 20-year, retrospective, multicenter cohort were stratified by the presence (LVI+) or absence (LVI-) of LVI. Outcomes (local recurrence, in-transit metastasis, nodal metastasis, disease-specific death) were compared based on low (Brigham and Women's Hospital [BWH] stage T1/T2a) and high (BWH T2b/T3) tumor stages. RESULTS: Of the 10,707 tumors, 78 had LVI. The analysis of low-stage BWH tumors showed the LVI+ group had a significantly higher 5-year cumulative incidence of local recurrence (LVI+: 12.3%; LVI-: 1.1%; P < .01), metastasis (LVI+: 4.2%; LVI-: 0.4%; P < .01), and disease-specific death (LVI+: 16.2%; LVI-: 0.4%; P < .01). The analysis of BWH high-stage tumors showed the LVI+ group maintained a higher 5-year cumulative incidence of metastasis (LVI+: 28.5%; LVI-: 16.8%; P = .06) and disease-specific death (LVI+: 25.3%; LVI-: 13.9%; P = .03), however, there was no difference in local recurrence (LVI+: 16.3%; LVI-: 15.8%; P = .11). LIMITATIONS: Retrospective study design. CONCLUSION: LVI+ cutaneous squamous cell carcinomas have higher rates of metastasis and death at 5 years. Future staging systems should consider incorporating LVI.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Kus KJB, Murad F, Smile TD, et al. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion. J Am Acad Dermatol. 2021. PMID: 34774657. doi:10.1016/j.jaad.2021.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。